IL17A and chronic graft versus host disease: In a mouse model of chronic GVHD, it was reported that ex vivo cultured MDSCs could modulate chronic GVHD presumably by preventing thymic tissue damages and reducing the percentages of CD4+ T cells that produced IL-17 (Th17 cells) and IL-4 (Th2 cells) (44).